The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Alternatives to overcoming bacterial resistances: State-of-the-art
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Ecology of prokaryotic viruses
Weinbauer, M. G. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2003.08.001 · Cited by 1,771
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D., Guerra, B., Mullany, P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,136
Protein delivery into eukaryotic cells by type III secretion machines
Galán, J. E., & Wolf-Watz, H. (2006) · Nature · doi:10.1038/nature05272 · Cited by 1,041
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
Liposomal Drug Delivery Systems: An Update Review
Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 906
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Corr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C., & Gahan, C. G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700440104 · Cited by 853
Bacteriophage Host Range and Bacterial Resistance
Hyman, P., & Abedon, S. T. (2010) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(10)70007-1 · Cited by 819
5500 Phages examined in the electron microscope
Ackermann, H.-W. (2007) · Archives of Virology · doi:10.1007/s00705-006-0849-1 · Cited by 752
Use of Ichip for High-Throughput In Situ Cultivation of “Uncultivable” Microbial Species
Nichols, D., Cahoon, N., Trakhtenberg, E. M., Pham, L., Mehta, A., Belanger, A., Kanigan, T., Lewis, K., & Epstein, S. S. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01754-09 · Cited by 732
German Outbreak of Escherichia coli O104:H4 Associated with Sprouts
Buchholz, U., Bernard, H., Werber, D., Böhmer, M. M., Remschmidt, C., Wilking, H., Deleré, Y., an der Heiden, M., Adlhoch, C., Dreesman, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106482 · Cited by 721
Bacteriocins from lactic acid bacteria: Production, purification, and food applications
De Vuyst, L., & Leroy, F. (2007) · Microbial Physiology · doi:10.1159/000104752 · Cited by 708
The influence of external factors on bacteriophages—review
Jończyk, E., Kłak, M., Międzybrodzki, R., & Górski, A. (2011) · Folia Microbiologica · doi:10.1007/s12223-011-0039-8 · Cited by 705
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Multifunctional cationic host defence peptides and their clinical applications
Yeung, A. T. Y., Gellatly, S. L., & Hancock, R. E. W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0710-x · Cited by 610
Antimicrobial peptides: an overview of a promising class of therapeutics
Giuliani, A., Pirri, G., & Nicoletto, S. (2007) · Open Life Sciences · doi:10.2478/s11535-007-0010-5 · Cited by 606
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
Nelson, D., Loomis, L., & Fischetti, V. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038398 · Cited by 578
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Cathelicidins: family of antimicrobial peptides. A review
Kościuczuk, E. M., Lisowski, P., Jarczak, J., Strzałkowska, N., Jóźwik, A., Horbańczuk, J., Krzyżewski, J., Zwierzchowski, L., & Bagnicka, E. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1997-x · Cited by 570
Rogosch, T., Kerzel, S., Hoi, K. H., Zhang, Z., Maier, R. F., Ippolito, G. C., & Zemlin, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00176 · Cited by 555
Bacterial efflux pump inhibitors from natural sources
Stavri, M., Piddock, L. J. V., & Gibbons, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl460 · Cited by 547
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
Antibiotics in animal feed and their role in resistance development
Wegener, H. C. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.09.009 · Cited by 517
Merabishvili, M., Pirnay, J.-P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J., Van Parys, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004944 · Cited by 511
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Phage-Host Interaction: an Ecological Perspective
Chibani-Chennoufi, S., Bruttin, A., Dillmann, M.-L., & Brüssow, H. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.12.3677-3686.2004 · Cited by 511
Antimicrobial Peptides for Therapeutic Applications: A Review
Seo, M.-D., Won, H.-S., Kim, J.-H., Mishig-Ochir, T., & Lee, B.-J. (2012) · Molecules · doi:10.3390/molecules171012276 · Cited by 492
Aarestrup, F. M., Agerso, Y., Gerner–Smidt, P., Madsen, M., & Jensen, L. B. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00130-9 · Cited by 486
Bacteriophage lysins as effective antibacterials
Fischetti, V. A. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.012 · Cited by 477
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.6.42801 · Cited by 468
Listeria--review of epidemiology and pathogenesis.
Ramaswamy, V., Cresence, V. M., Rejitha, J. S., Lekshmi, M. U., Dharsana, K. S., Prasad, S. P., & Vijila, H. M. (2007) · PubMed · Cited by 451
Application of bacteriocins in vegetable food biopreservation
Settanni, L., & Corsetti, A. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2007.09.001 · Cited by 441
Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
Fischetti, V. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.002 · Cited by 438
Antimicrobial Peptides: Primeval Molecules or Future Drugs?
Peters, B. M., Shirtliff, M. E., & Jabra-Rizk, M. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001067 · Cited by 425
The dual role of bacteriocins as anti- and probiotics
Gillor, O., Etzion, A., & Riley, M. A. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1726-5 · Cited by 416
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., et al. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0408-9 · Cited by 409
Antimicrobial Peptides: Old Molecules with New Ideas
Nakatsuji, T., & Gallo, R. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.387 · Cited by 394
Microcins, gene-encoded antibacterial peptides from enterobacteria
Duquesne, S., Destoumieux-Garzón, D., Peduzzi, J., & Rebuffat, S. (2007) · Natural Product Reports · doi:10.1039/b516237h · Cited by 390
Izadpanah, A., & Gallo, R. L. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.08.026 · Cited by 380
Bacteriophages: an appraisal of their role in the treatment of bacterial infections
Hanlon, G. W. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.04.006 · Cited by 376
BACTIBASE second release: a database and tool platform for bacteriocin characterization
Hammami, R., Zouhir, A., Le Lay, C., Ben Hamida, J., & Fliss, I. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-22 · Cited by 369
Recombinant vaccines and the development of new vaccine strategies
Nascimento, I. P., & Leite, L. C. C. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500142 · Cited by 367
Bacteriophage for Biocontrol of Foodborne Pathogens: Calculations and Considerations
Hagens, S., & Loessner, M. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725429 · Cited by 366
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
Carlet, J., Jarlier, V., Harbarth, S., Voss, A., Goossens, H., Pittet, D., & Forum, T. P. O. T. 3. W. H.-A. I. (2012) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-1-11 · Cited by 350
Pediocins: The bacteriocins of Pediococci. Sources, production, properties and applications
Papagianni, M., & Anastasiadou, S. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-3 · Cited by 342
Bacteriophage Endolysins as a Novel Class of Antibacterial Agents
Borysowski, J., Weber-Dąbrowska, B., & Górski, A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100402 · Cited by 338
Freire-Moran, L., Aronsson, B., Manz, C., Gyssens, I. C., So, A. D., Monnet, D. L., & Cars, O. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.003 · Cited by 335
Park, S.-C., Park, Y., & Hahm, K.-S. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095971 · Cited by 327
Society's failure to protect a precious resource: antibiotics
Carlet, J., Collignon, P., Goldmann, D., Goossens, H., Gyssens, I. C., Harbarth, S., Jarlier, V., Levy, S. B., N'Doye, B., Pittet, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60401-7 · Cited by 322
The WHO policy package to combat antimicrobial resistance
Leung, E., Weil, D. E., Raviglione, M., & Nakatani, H. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.088435 · Cited by 320
Rang, H. P., Ritter, J., Flower, R. J., & Henderson, G. (2014) · Cited by 313
Burton, J. P., Chilcott, C. N., Moore, C. J., Speiser, G., & Tagg, J. R. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.02837.x · Cited by 307
Bacteriophages Can Treat and Prevent Pseudomonas aeruginosa Lung Infections
Debarbieux, L., Leduc, D., Maura, D., Morello, E., Criscuolo, A., Grossi, O., Balloy, V., & Touqui, L. (2010) · The Journal of Infectious Diseases · doi:10.1086/651135 · Cited by 304
Aarestrup, F. M. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0085 · Cited by 298
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
Phage therapy: Facts and fiction
Skurnik, M., & Strauch, E. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.09.002 · Cited by 296
Antimicrobial Peptides: Versatile Biological Properties
Pushpanathan, M., Gunasekaran, P., & Rajendhran, J. (2013) · International Journal of Peptides · doi:10.1155/2013/675391 · Cited by 292
Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
(2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.011 · Cited by 289
The strange history of phage therapy
Summers, W. C. (2012) · Bacteriophage · doi:10.4161/bact.20757 · Cited by 284
Recover the lost art of drug discovery
Lewis, K. (2012) · Nature · doi:10.1038/485439a · Cited by 276
Morello, E., Saussereau, E., Maura, D., Huerre, M., Touqui, L., & Debarbieux, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016963 · Cited by 275
Bacteriophage and their lysins for elimination of infectious bacteria
O'Flaherty, S., Ross, R. P., & Coffey, A. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00176.x · Cited by 272
Nabel, G. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1204186 · Cited by 271
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
Loeffler, J. M., Djurkovic, S., & Fischetti, V. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6199-6204.2003 · Cited by 269
Nissen-Meyer, J., Rogne, P., Oppegard, C., Haugen, H., & Kristiansen, P. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109787048661 · Cited by 256
Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics
Sang, Y., & Blecha, F. (2008) · Animal Health Research Reviews · doi:10.1017/s1466252308001497 · Cited by 254
Taking aim on bacterial pathogens: from phage therapy to enzybiotics
Hermoso, J. A., García, J. L., & García, P. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.08.002 · Cited by 251
Viertel, T. M., Ritter, K., & Horz, H.-P. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku173 · Cited by 243
O’Flaherty, S., Ross, R. P., Meaney, W. J., Fitzgerald, G. F., Elbreki, M., & Coffey, A. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.4.1836-1842.2005 · Cited by 243
Bacteriophage penetration in vertebrates
Dabrowska, K., Switala-Jelen, K., Opolski, A., Weber-Dabrowska, B., & Gorski, A. (2005) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02422.x · Cited by 240
Daniel, A., Euler, C., Collin, M., Chahales, P., Gorelick, K. J., & Fischetti, V. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01625-09 · Cited by 233
Cheng, Q., Nelson, D., Zhu, S., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.111-117.2005 · Cited by 233
Rashel, M., Uchiyama, J., Ujihara, T., Uehara, Y., Kuramoto, S., Sugihara, S., Yagyu, K., Muraoka, A., Sugai, M., Hiramatsu, K., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521305 · Cited by 232
Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model
Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S. O., & Ljungh, Å. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh387 · Cited by 231
Structural and functional stabilization of protein entities: state-of-the-art
Balcão, V. M., & Vila, M. M. D. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.005 · Cited by 230
Self-citationRecombinant bacteriophage lysins as antibacterials
Fenton, M., McAuliffe, O., O’Mahony, J., & Coffey, A. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.1.9818 · Cited by 225
Sass, P., & Bierbaum, G. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01616-06 · Cited by 222
Phage Therapy for Plant Disease Control
Balogh, B., Jones, J., Iriarte, F., & Momol, M. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725302 · Cited by 220
Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
Jado, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg485 · Cited by 216
Chan, B. K., & Abedon, S. T. (2012) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-394805-2.00001-4 · Cited by 212
PlyC: A multimeric bacteriophage lysin
Nelson, D., Schuch, R., Chahales, P., Zhu, S., & Fischetti, V. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604521103 · Cited by 207
Fighting bacterial infections—Future treatment options
Fernebro, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.001 · Cited by 199
Tanji, Y., Shimada, T., Fukudomi, H., Miyanaga, K., Nakai, Y., & Unno, H. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.100.280 · Cited by 196
Chhibber, S., Kaur, S., & Kumari, S. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.2008/002873-0 · Cited by 194
Scholl, D., Rogers, S., Adhya, S., & Merril, C. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2509-2515.2001 · Cited by 192
Antimicrobial Peptides – Promising Alternatives to Conventional Antibiotics
Baltzer, S. A., & Brown, M. H. (2011) · Microbial Physiology · doi:10.1159/000331009 · Cited by 191
Gravesen, A., Ramnath, M., Rechinger, K. B., Andersen, N., Jänsch, L., Héchard, Y., Hastings, J. W., & Knøchel, S. (2002) · Microbiology · doi:10.1099/00221287-148-8-2361 · Cited by 190
A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
Balu, S., Reljic, R., Lewis, M. J., Pleass, R. J., McIntosh, R., van Kooten, C., van Egmond, M., Challacombe, S., Woof, J. M., & Ivanyi, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003189 · Cited by 184
Obeso, J. M., Martínez, B., Rodríguez, A., & García, P. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.08.010 · Cited by 179
Antimicrobial resistance: its emergence and transmission
Boerlin, P., & Reid-Smith, R. J. (2008) · Animal Health Research Reviews · doi:10.1017/s146625230800159x · Cited by 178
Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12
Burton, J. P., Wescombe, P. A., Moore, C. J., Chilcott, C. N., & Tagg, J. R. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.4.3050-3053.2006 · Cited by 177
Łęski, T. A., & Tomasz, A. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.5.1815-1824.2005 · Cited by 175
Donabedian, S. M., Thal, L. A., Hershberger, E., Perri, M. B., Chow, J. W., Bartlett, P., Jones, R., Joyce, K., Rossiter, S., Gay, K., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.3.1109-1113.2003 · Cited by 174
Suttmann, H., Retz, M., Paulsen, F., Harder, J., Zwergel, U., Kamradt, J., Wullich, B., Unteregger, G., Stöckle, M., & Lehmann, J. (2008) · BMC Urology · doi:10.1186/1471-2490-8-5 · Cited by 173
Schmelcher, M., Powell, A. M., Becker, S. C., Camp, M. J., & Donovan, D. M. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07050-11 · Cited by 172
Kaewsrichan, J., Peeyananjarassri, K., & Kongprasertkit, J. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00124.x · Cited by 172
Monoclonal antibody-based therapies for microbial diseases
Saylor, C., Dadachova, E., & Casadevall, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.105 · Cited by 172
The Potential of Antimicrobial Peptides as Biocides
Laverty, G., Gorman, S. P., & Gilmore, B. F. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12106566 · Cited by 171
The Two-Peptide Class II Bacteriocins: Structure, Production, and Mode of Action
Oppegård, C., Rogne, P., Emanuelsen, L., Kristiansen, P. E., Fimland, G., & Nissen-Meyer, J. (2007) · Microbial Physiology · doi:10.1159/000104750 · Cited by 170
Meier, S., Weber, R., Zbinden, R., Ruef, C., & Hasse, B. (2011) · Infection · doi:10.1007/s15010-011-0132-6 · Cited by 169
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167
Desriac, F., Defer, D., Bourgougnon, N., Brillet, B., Le Chevalier, P., & Fleury, Y. (2010) · Marine Drugs · doi:10.3390/md8041153 · Cited by 167
Kim, O. Y., Hong, B. S., Park, K.-S., Yoon, Y. J., Choi, S. J., Lee, W. H., Roh, T.-Y., Lötvall, J., Kim, Y.-K., & Gho, Y. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200742 · Cited by 166
Off-label abuse of antibiotics by bacteria
Viswanathan, V. (2014) · Gut Microbes · doi:10.4161/gmic.28027 · Cited by 166
Zimmer, M., Vukov, N., Scherer, S., & Loessner, M. J. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5311-5317.2002 · Cited by 165
Transition state analogs of 5′-methylthioadenosine nucleosidase disrupt quorum sensing
Gutierrez, J. A., Crowder, T., Rinaldo-Matthis, A., Ho, M.-C., Almo, S. C., & Schramm, V. L. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.153 · Cited by 164
Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs
Johnson, R. P., Gyles, C. L., Huff, W. E., Ojha, S., Huff, G. R., Rath, N. C., & Donoghue, A. M. (2008) · Animal Health Research Reviews · doi:10.1017/s1466252308001576 · Cited by 161
Antibacterial Peptides “Bacteriocins”: An Overview of Their Diverse Characteristics and Applications
NISHIE, M., NAGAO, J.-I., & SONOMOTO, K. (2012) · Biocontrol Science · doi:10.4265/bio.17.1 · Cited by 158
Almeida, A., Cunha, Â., Gomes, N. C. M., Alves, E., Costa, L., & Faustino, M. A. F. (2009) · Marine Drugs · doi:10.3390/md7030268 · Cited by 157
Housby, J. N., & Mann, N. H. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.03.006 · Cited by 155
Efficacy of Bacteriophage Therapy in a Model ofBurkholderia cenocepaciaPulmonary Infection
Carmody, L. A., Gill, J. J., Summer, E. J., Sajjan, U. S., Gonzalez, C. F., Young, R., & LiPuma, J. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/649227 · Cited by 154
Hung, C., Kuo, C.-F., Wang, C.-H., Wu, C.-M., & Tsao, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01123-10 · Cited by 153
Collins, B., Curtis, N. J., Cotter, P. D., Hill, C., & Ross, R. P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00503-10 · Cited by 153
Gotteland, M., Andrews, M., Toledo, M., Muñoz, L. A., Cáceres, P., Anziani, A., Wittig, E., Speisky, H., & Salazar, G. (2008) · Nutrition · doi:10.1016/j.nut.2008.01.007 · Cited by 150
Genetically Engineered Bacteriocins and their Potential as the Next Generation of Antimicrobials
Gillor, O., Nigro, L. M., & Riley, M. A. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381666 · Cited by 143
Emerging Themes and Therapeutic Prospects for Anti-Infective Peptides
Yount, N. Y., & Yeaman, M. R. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134535 · Cited by 143
Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations
Wijagkanalan, W., Kawakami, S., & Hashida, M. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0339-8 · Cited by 139
Metagenomic analysis of DNA viruses in a wastewater treatment plant in tropical climate
Tamaki, H., Zhang, R., Angly, F. E., Nakamura, S., Hong, P., Yasunaga, T., Kamagata, Y., & Liu, W. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02630.x · Cited by 136
Virus hybrids as nanomaterials for biotechnology
Soto, C. M., & Ratna, B. R. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.07.004 · Cited by 136
The role of regulated clinical trials in the development of bacteriophage therapeutics
Parracho, H. M. R. T., Burrowes, B. H., & Enright, M. C. (2012) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000050 · Cited by 133
Sizing the Holin Lesion with an Endolysin-β-Galactosidase Fusion
Wang, I., Deaton, J., & Young, R. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.779-787.2003 · Cited by 132
Dabour, N., Zihler, A., Kheadr, E., Lacroix, C., & Fliss, I. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2009.05.005 · Cited by 132
Resistance-resistant antibiotics
Oldfield, E., & Feng, X. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.10.007 · Cited by 132
Fernández, L., Delgado, S., Herrero, H., Maldonado‐Barragán, A., & Rodríguez, J. M. (2008) · Journal of Human Lactation · doi:10.1177/0890334408317435 · Cited by 131
Mechanisms of Resistance to Bacteriocins Targeting the Mannose Phosphotransferase System
Kjos, M., Nes, I. F., & Diep, D. B. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02602-10 · Cited by 129
Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo
Cao, L., Chao, D., Li, Z., Fan, Z., Song, Y., Wu, Y., Cao, Z., & Li, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040135 · Cited by 127
Class IIa Bacteriocins: Diversity and New Developments
Cui, Y., Zhang, C., Wang, Y., Shi, J., Zhang, L., Ding, Z., Qu, X., & Cui, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131216668 · Cited by 125
Vadyvaloo, V., Hastings, J. W., van der Merwe, M. J., & Rautenbach, M. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5223-5230.2002 · Cited by 123
Kjos, M., Salehian, Z., Nes, I. F., & Diep, D. B. (2010) · Journal of Bacteriology · doi:10.1128/jb.00777-10 · Cited by 121
Cell-surface alterations in class IIa bacteriocin-resistant Listeria monocytogenes strains
Vadyvaloo, V., Arous, S., Gravesen, A., Héchard, Y., Chauhan-Haubrock, R., Hastings, J. W., & Rautenbach, M. (2004) · Microbiology · doi:10.1099/mic.0.27059-0 · Cited by 120
Availability of Antibiotics for Purchase Without a Prescription on the Internet
Mainous, A. G., Everett, C. J., Post, R. E., Díaz, V. A., & Hueston, W. J. (2009) · The Annals of Family Medicine · doi:10.1370/afm.999 · Cited by 120
Kristian, S. A., Lauth, X., Nizet, V., Goetz, F., Neumeister, B., Peschel, A., & Landmann, R. M. (2003) · The Journal of Infectious Diseases · doi:10.1086/376533 · Cited by 120
Nieves, W., Asakrah, S. K., Qazi, O., Brown, K. A., Kurtz, J. R., AuCoin, D. P., McLachlan, J. B., Roy, C. J., & Morici, L. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.058 · Cited by 115
Antimicrobial Peptides: Multifunctional Drugs for Different Applications
Brandenburg, L., Merres, J., Albrecht, L.-J., Varoga, D. J., & Pufe, T. (2012) · Polymers · doi:10.3390/polym4010539 · Cited by 115
Peptidoglycan Hydrolase Fusions Maintain Their Parental Specificities
Donovan, D. M., Dong, S., Garrett, W., Rousseau, G. M., Moineau, S., & Pritchard, D. G. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.4.2988-2996.2006 · Cited by 115
Lantibiotics, Class I Bacteriocins from the Genus Bacillus
Lee, H.-J., & Kim, H. (2011) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1010.10017 · Cited by 114
May, J. J., Finking, R., Wiegeshoff, F., Weber, T. T., Bandur, N. G., Koert, U., & Marahiel, M. A. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04700.x · Cited by 113
Amer, L. S., Bishop, B., & van Hoek, M. L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.073 · Cited by 113
Preparing for HPV vaccination in South Africa: Key challenges and opinions
Harries, J., Moodley, J., Barone, M. A., Mall, S., & Sinanovic, E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.10.033 · Cited by 113
Singh, P. K., Chittpurna, Ashish, Sharma, V., Patil, P. B., & Korpole, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031498 · Cited by 109
Blay, G. L., Lacroix, C., Zihler, A., & Fliss, I. (2007) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02178.x · Cited by 107
Slaninová, J., Mlsová, V., Kroupová, H., Alán, L., Tůmová, T. (., Monincová, L., Borovičková, L., Fučík, V., & Čeřovský, V. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.002 · Cited by 105
Klotz, M. G. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00001 · Cited by 105
Burton, J. P., Wescombe, P. A., Macklaim, J. M., Chai, M. H. C., MacDonald, K. W., Hale, J. D. F., Tagg, J. R., Reid, G., Gloor, G. B., & Cadieux, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065991 · Cited by 104
Lactococcin Q, a Novel Two-Peptide Bacteriocin Produced by Lactococcus lactis QU 4
Zendo, T., Koga, S., Shigeri, Y., Nakayama, J., & Sonomoto, K. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.5.3383-3389.2006 · Cited by 103
A Randomized Study of a Monoclonal Antibody (Pagibaximab) to Prevent Staphylococcal Sepsis
Weisman, L. E., Thackray, H. M., Steinhorn, R. H., Walsh, W. F., Lassiter, H. A., Dhanireddy, R., Brozanski, B. S., Palmer, K. G., Trautman, M. S., ESCOBEDO, M. B., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-3081 · Cited by 103
Antibodies for the treatment of bacterial infections: current experience and future prospects
Bebbington, C. R., & Yarranton, G. T. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.002 · Cited by 100
X-ray crystal structure of the streptococcal specific phage lysin PlyC
McGowan, S., Buckle, A. M., Mitchell, M. S., Hoopes, J. T., Gallagher, D. T., Heselpoth, R. D., Shen, Y., Reboul, C. F., Law, R. H. P., Fischetti, V. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208424109 · Cited by 99
Bacterial quorum sensing: a new target for anti-infective immunotherapy
Kaufmann, G. F., Park, J., & Janda, K. D. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.6.719 · Cited by 99
Development of Class IIa Bacteriocins as Therapeutic Agents
Lohans, C. T., & Vederas, J. C. (2011) · International Journal of Microbiology · doi:10.1155/2012/386410 · Cited by 97
Introducing yesterday‘s phage Therapy in today‘s Medicine
Pirnay, J., Verbeken, G., Rose, T., Jennes, S., Zizi, M., Huys, I., Lavigne, R., Merabishvili, M., Vaneechoutte, M., Buckling, A., et al. (2012) · Future Virology · doi:10.2217/fvl.12.24 · Cited by 95
Future antibiotics scenarios: is the tide starting to turn?
Theuretzbacher, U. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.02.005 · Cited by 91
Bacteriophages as twenty-first century antibacterial tools for food and medicine
Maura, D., & Debarbieux, L. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3227-1 · Cited by 90
Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7
Chen, Y.-Q., Cao, L., Zhong, M., Zhang, Y., Chen, H., Li, Q., Yang, J., Zhou, D., Shi, W. K., He, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034947 · Cited by 87
Campos, J., Ferech, M., Lázaro, E., de Abajo, F. J., Oteo, J., Stephens, P. J., & Goossens, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm248 · Cited by 86
McInturff, J. E., Wang, S.-J., Machleidt, T., Lin, T. R., Oren, A., Hertz, C. J., Krutzik, S. R., Hart, S. A., Zeh, K., Anderson, D. H., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23805.x · Cited by 85
A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV
Yan, R., Zhao, Z., He, Y., Wu, L., Cai, D., Hong, W., Wu, Y., Cao, Z., Zheng, C., & Li, W. (2010) · Peptides · doi:10.1016/j.peptides.2010.10.008 · Cited by 84
Biological preservation of foods–Bacteriocins of lactic acid bacteria
Jeevaratnam, K., Jamuna, M., & Bawa, A. S. (2005) · Cited by 83
Ojala, V., Laitalainen, J., & Jalasvuori, M. (2013) · Evolutionary Applications · doi:10.1111/eva.12076 · Cited by 82
Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus
Manoharadas, S., Witte, A., & Bläsi, U. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.09.003 · Cited by 81
Hillman, J. D., Mo, J., McDonell, E., Cvitkovitch, D. G., & Hillman, C. H. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03316.x · Cited by 80
Rajaram, G., Manivasagan, P., Thilagavathi, B., & Saravanakumar, A. (2010) · Advance Journal of Food Science and Technology · Cited by 80
Type III secretion systems shape up as they ship out
Marlovits, T. C., & Stebbins, C. E. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.11.001 · Cited by 78
Kazazić, M., Nissen-Meyer, J., & Fimland, G. (2002) · Microbiology · doi:10.1099/00221287-148-7-2019 · Cited by 77
Johnsen, P. J., Østerhus, J. I., Sletvold, H., Sørum, M. E., Kruse, H., Nielsen, K. M., Simonsen, G. S., & Sundsfjord, A. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.1.159-168.2005 · Cited by 77
Design of Host Defence Peptides for Antimicrobial and Immunity Enhancing Activities
McPhee, J. B., Scott, M. G., & Hancock, R. E. W. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053764558 · Cited by 76
Kawada‐Matsuo, M., Yoshida, Y., Zendo, T., Nagao, J.-I., Oogai, Y., Nakamura, Y., Sonomoto, K., Nakamura, N., & Komatsuzawa, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069455 · Cited by 76
Anti-bacterial monoclonal antibodies: Back to the future?
Oleksiewicz, M. B., Nagy, G., & Nagy, E. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.06.001 · Cited by 75
A Randomized Study of a Monoclonal Antibody (Pagibaximab) to Prevent Staphylococcal Sepsis
(2011) · PEDIATRICS · doi:10.1542/peds.2010-3081d · Cited by 72
Antimicrobial peptides and proteins of the horse - insights into a well-armed organism
Bruhn, O., Grötzinger, J., Cascorbi, I., & Jung, S. (2011) · Veterinary Research · doi:10.1186/1297-9716-42-98 · Cited by 68
Brand, A. M., de Kwaadsteniet, M., & Dicks, L. M. T. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02948.x · Cited by 66
Pierce, M. M. (2015) · AccessScience · doi:10.1036/1097-8542.br0817152 · Cited by 65
Pouillot, F., Blois, H., & Iris, F. (2010) · Biosecurity and Bioterrorism Biodefense Strategy Practice and Science · doi:10.1089/bsp.2009.0057 · Cited by 64
Biomedical Applications of Fermenticin HV6b Isolated fromLactobacillus fermentumHV6b MTCC10770
Kaur, B., Balgir, P. P., Mittu, B., Kumar, B., & Garg, N. (2013) · BioMed Research International · doi:10.1155/2013/168438 · Cited by 61
Tessema, G. T., Møretrø, T., Köhler, A., Axelsson, L. T., & Naterstad, K. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00608-09 · Cited by 61
Carlet, J. M., & Mainardi, J. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03702.x · Cited by 60
Feasibility of Radioimmunotherapy of Experimental Pneumococcal Infection
Dadachova, E., Burns, T., Bryan, R. A., Apostolidis, C., Brechbiel, M. W., Nosanchuk, J. D., Casadevall, A., & Pirofski, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1624-1629.2004 · Cited by 60
Cited by
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Use of antibiotics in broiler production: Global impacts and alternatives
Mehdi, Y., Létourneau-Montminy, M.-P., Gaucher, M.-L., Chorfi, Y., Suresh, G., Rouissi, T., Brar, S. K., Côté, C., Ramirez, A. A., & Godbout, S. (2018) · Animal Nutrition · doi:10.1016/j.aninu.2018.03.002 · Cited by 652
Biotechnological applications of bacteriophages: State of the art
Harada, L. K., Silva, E. C., Campos, W. F., Del Fiol, F. S., Vila, M., Dąbrowska, K., Krylov, V. N., & Balcão, V. M. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.04.007 · Cited by 318
Self-citationSharma, C., Rokana, N., Chandra, M., Singh, B. P., Gulhane, R. D., Gill, J. P. S., Ray, P., Puniya, A. K., & Panwar, H. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2017.00237 · Cited by 308
An overview of antimicrobial peptides and the latest advances in their development
Sierra, J. M., Fusté, E., Rabanal, F., Vinuesa, T., & Viñas, M. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1315402 · Cited by 283
Metadata
- Authors
- Rios, A. C., Moutinho, C. G., Pinto, F. C., Del Fiol, F. S., Jozala, A., Chaud, M. V., Vila, M. M. D. C., Teixeira, J. A., & Balcão, V. M.
- Venue
- Microbiological Research
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 191
- Pages
- 51-80
- ISSN
- 0944-5013 (ISSN-L)
- OpenAlex
- W2380949445
- Cited by
- 263
- References
- 228
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.